QURE Stock’s Global Rollercoaster: How a Dutch Gene-Therapy Firm Became the World’s Favorite Lottery Ticket
Qure Stock: A Nasdaq Fever Dream in Four Acts (and One Margin Call) Act I – Singapore, 3:47 a.m. A junior quant from DBS, still smelling of last-night laksa, watches QURE spike 42 % on no news whatsoever. Somewhere in Delaware, a pre-revenue gene-therapy hopeful named QURE—officially “uniQure N.V.”—has become the latest chew-toy for Reddit’s…